Oxime derivatives, their preparation and their therapeutic use

Details Oxime derivatives, their preparation and their therapeutic use Oxime derivatives, their preparation and their therapeutic use

1995-10-05

1997-12-30

Ivy, C. Warren

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

5462697, 5462714, 5462727, A61K 3144, C07D41712

Patent

active

057030960

ABSTRACT:
Compounds of formula (I): ##STR1## wherein: R.sup.1 is hydrogen or alkyl; R.sup.2 is alkylene; R.sup.3 is hydrogen, alkyl, alkoxy, alkylthio, halogen, nitro group, amino group, monoalkylamino, dialkylamino, aryl, or aralkyl; X is aryl, or aromatic heterocyclic; Y is oxygen, sulfur or a group of formula >N-R.sup.4, in which R.sup.4 is hydrogen, alkyl or acyl; and Z is a group of formula (Za), (Zb), (Zc) or (Zd): ##STR2## and salts thereof can be used to treat or prevent are included those arising from hyperlipidemia, hyperglycemia, obesity, impaired glucose tolerance (IGT), insulin resistant non-IGT (NGT), non-diagnostic glucose tolerance, insulin resistance, diabetic complications, fatty liver, polycystic ovary syndrome (PCOS) and gestational diabetes mellitus (GDM); in addition the compounds of the present invention have aldose reductase inhibitory activity.

REFERENCES:
patent: 4728739 (1988-03-01), Kees et al.
patent: 5002953 (1991-03-01), Hindley
patent: 5391565 (1995-02-01), Hindley
Takashi Sohda et al, "Studies on Antidiabetic Agents II. .sup.1) Synthesis (ADD-3878) and Its Derivatives", Chem. Pharm. Bull. 30, 1982, pp. 3580-3600.

Affiliated with

Also associated with

Rating

Oxime derivatives, their preparation and their therapeutic use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxime derivatives, their preparation and their therapeutic use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxime derivatives, their preparation and their therapeutic use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-202625